Name: UMIN ID:
Unique ID issued by UMIN | UMIN000019917 |
---|---|
Receipt number | R000022473 |
Scientific Title | Efficacy and safety of dose-escalating lenalidomide and dexamethasone (Rd) for unfit patients with relapsed or refractory multiple myeloma |
Date of disclosure of the study information | 2015/11/24 |
Last modified on | 2019/11/28 15:21:03 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2015/11/24 20:25:24 | ||
2 | Update | 2015/12/03 04:23:00 | Acronym Acronym |
|
3 | Update | 2016/11/25 13:15:25 | Name of primary person or sponsor Organization |
|
4 | Update | 2017/05/26 11:21:20 | URL releasing protocol |
|
5 | Update | 2018/12/03 12:19:51 | Recruitment status |
|
6 | Update | 2019/11/28 12:55:35 | 1st name of lead principal investigator Last name of lead principal investigator 1st name of lead principal investigator Last name of lead principal investigator Zip code Last name of contact person Last name of contact person Zip code Tel1 Email1 Organization Organization Address Address Tel |
|
7 | Update | 2019/11/28 12:57:11 | Number of participants that the trial has enrolled |
|
8 | Update | 2019/11/28 13:07:37 | Date of IRB Anticipated trial start date Last follow-up date |
|
9 | Update | 2019/11/28 15:21:03 | Organization |